Mehri S. Mckellar
Distinguished in HIV/AIDS

Dr. Mehri S. Mckellar

Infectious Disease
Duke Health
Duke Infectious Diseases Clinic - Clinic 1K
40 Duke Medicine Cir, 
Durham, NC 
On Staff At
Accepting New Patients
Offers Telehealth
Distinguished in HIV/AIDS
Duke Health
Duke Infectious Diseases Clinic - Clinic 1K
40 Duke Medicine Cir, 
Durham, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

I am an infectious diseases physician with a focus on persons who have HIV. One of my major clinical and research interests is HIV prevention, such as rapid HIV testing and prevention through pre-exposure prophylaxis or PrEP in which people can take one pill per day to prevent HIV. I serve as the Medical Director of the Duke PrEP Clinic and have a number of projects in the community involving PrEP, including with populations who are difficult to reach. I am originally from Arizona, and love to hike, ski, and spend time with my family and friends.

Dr. Mckellar is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Her clinical research consists of co-authoring 47 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 39 articles and participated in 3 clinical trials in the study of HIV/AIDS.

Specialties
Infectious Disease
Licenses
Internal Medicine in CA
Board Certifications
American Board Of Internal Med, Infectious Diseases
Fellowships
Infectious Diseases, University of Utah Medical Center
Hospital Affiliations
Duke University Hospital
Languages Spoken
English
Spanish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Duke Infectious Diseases Clinic - Clinic 1K
40 Duke Medicine Cir, Durham, NC 27710
Call: 919-668-3197

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2a Multicentre, Randomized, Open-Label, Two-Part Adaptive Design Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A, an HIV-1 Specific Broadly Neutralizing Human Monoclonal Antibody in Antiretroviral-naïve HIV-1-Infected Adults
A Phase 2a Multicentre, Randomized, Open-Label, Two-Part Adaptive Design Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A, an HIV-1 Specific Broadly Neutralizing Human Monoclonal Antibody in Antiretroviral-naïve HIV-1-Infected Adults
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Biological
Study Drug: GSK3810109A
Study Phase: Phase 2
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
Study Drugs: Cabotegravir, Rilpivirine, BIKTARVY
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Tenofovir alafenamide based regimen
Study Phase: Phase 3
Providing A Resource: Telemedicine at Needle Exchanges to Reach Under-served Populations - Greensboro
Providing A Resource: Telemedicine at Needle Exchanges to Reach Under-served Populations - Greensboro
Enrollment Status: Completed
Publish Date: April 27, 2023
Intervention Type: Drug
Study Drugs: Suboxone, Truvada, Mavyret
Study Phase: Not Applicable
IGHID 11417 - The Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection: Impact on the Latent HIV Reservoir and Long-Term Immunologic Effect
IGHID 11417 - The Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection: Impact on the Latent HIV Reservoir and Long-Term Immunologic Effect
Enrollment Status: Completed
Publish Date: November 22, 2021
Intervention Type: Drug
Study Phase: Not Applicable
View 4 Less Clinical Trials

47 Total Publications

Preexposure Prophylaxis to Prevent HIV Acquisition: Perceptions among Sexual and Gender Minority Individuals in North Carolina.
Preexposure Prophylaxis to Prevent HIV Acquisition: Perceptions among Sexual and Gender Minority Individuals in North Carolina.
Journal: Southern medical journal
Published: July 15, 2025
View All 47 Publications
Similar Doctors
Joseph J. Eron
Elite in HIV/AIDS
Dr. Joseph J. Eron
Infectious Disease
Elite in HIV/AIDS
Dr. Joseph J. Eron
Infectious Disease

University Of North Carolina At Chapel Hill

101 Manning Dr, 
Chapel Hill, NC 
 (9.5 miles away)
984-974-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Joseph Eron is an Infectious Disease provider in Chapel Hill, North Carolina. Dr. Eron is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, AIDS Dementia Complex, AIDS Dysmorphic Syndrome, Myelitis, and Tissue Biopsy. Dr. Eron is currently accepting new patients.

Myron S. Cohen
Elite in HIV/AIDS
Dr. Myron S. Cohen
Infectious Disease
Elite in HIV/AIDS
Dr. Myron S. Cohen
Infectious Disease
101 Manning Dr, 
Chapel Hill, NC 
 (9.5 miles away)
919-966-4996
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Myron Cohen is an Infectious Disease provider in Chapel Hill, North Carolina. Dr. Cohen is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, COVID-19, Urethritis, and Severe Acute Respiratory Syndrome (SARS). Dr. Cohen is currently accepting new patients.

Mina C. Hosseinipour
Elite in HIV/AIDS
Dr. Mina C. Hosseinipour
Infectious Disease
Elite in HIV/AIDS
Dr. Mina C. Hosseinipour
Infectious Disease

University Of North Carolina At Chapel Hill

101 Manning Dr, 
Chapel Hill, NC 
 (9.5 miles away)
984-974-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mina Hosseinipour is an Infectious Disease provider in Chapel Hill, North Carolina. Dr. Hosseinipour is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Cryptococcosis, Meningitis, and Kaposi Sarcoma. Dr. Hosseinipour is currently accepting new patients.

VIEW MORE HIV/AIDS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mckellar's expertise for a condition
ConditionClose
    • Distinguished
    • HIV/AIDS
      Dr. Mckellar is
      Distinguished
      . Learn about HIV/AIDS.
      See more HIV/AIDS experts
    • Advanced
    • AIDS Dementia Complex
      Dr. Mckellar is
      Advanced
      . Learn about AIDS Dementia Complex.
      See more AIDS Dementia Complex experts
    • AIDS Dysmorphic Syndrome
      Dr. Mckellar is
      Advanced
      . Learn about AIDS Dysmorphic Syndrome.
      See more AIDS Dysmorphic Syndrome experts
    • Myelitis
      Dr. Mckellar is
      Advanced
      . Learn about Myelitis.
      See more Myelitis experts
    • Experienced
    • Cellulitis
      Dr. Mckellar is
      Experienced
      . Learn about Cellulitis.
      See more Cellulitis experts
    • End-Stage Renal Disease (ESRD)
      Dr. Mckellar is
      Experienced
      . Learn about End-Stage Renal Disease (ESRD).
      See more End-Stage Renal Disease (ESRD) experts
    • Hepatitis
      Dr. Mckellar is
      Experienced
      . Learn about Hepatitis.
      See more Hepatitis experts
    • Lymphangitis
      Dr. Mckellar is
      Experienced
      . Learn about Lymphangitis.
      See more Lymphangitis experts
    • Nontuberculous Mycobacterial Lung Disease
      Dr. Mckellar is
      Experienced
      . Learn about Nontuberculous Mycobacterial Lung Disease.
      See more Nontuberculous Mycobacterial Lung Disease experts
    • Osteomyelitis
      Dr. Mckellar is
      Experienced
      . Learn about Osteomyelitis.
      See more Osteomyelitis experts
    View All 8 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.